MACROGENICS, INC. Operating Lease Liability
MACROGENICS, INC. (MGNX) had Operating Lease Liability of $36.76 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-09
- 2025-12-31: Operating Lease, Liability $36.76M.
- 2024-12-31: Operating Lease, Liability $37.46M.
- 2023-12-31: Operating Lease, Liability $33.97M.
- 2022-12-31: Operating Lease, Liability $34.83M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $36.76M 10-K · filed 2026-03-09 |
| 2024-12-31 | $37.46M 10-K · filed 2025-03-20 |
| 2023-12-31 | $33.97M 10-K · filed 2024-03-07 |
| 2022-12-31 | $34.83M 10-K · filed 2023-03-15 |
| 2021-12-31 | $25.47M 10-K · filed 2022-02-24 |
| 2020-12-31 | $29.25M 10-K · filed 2021-02-25 |
| 2019-12-31 | $30.57M 10-K · filed 2020-02-25 |
| 2019-09-30 | $31.54M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $27.92M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $28.78M 10-Q · filed 2019-05-01 |
| 2019-01-01 | $27.70M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |